Theriva Biologics, Inc. (TOVX) is a publicly traded Healthcare sector company. As of September 23, 2026, TOVX trades at $0.23 with a market cap of $10.59M and a P/E ratio of -0.11. TOVX moved +0.95% today. Year to date, TOVX is +9.70%; over the trailing twelve months it is -42.87%. Its 52-week range spans $0.16 to $1.75. Analyst consensus is buy with an average price target of $1.00. Rallies surfaces TOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for TOVX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.23 |
| Market Cap | $10.59M |
| P/E Ratio | -0.11 |
| EPS | $-2.08 |
| Dividend Yield | 0.05% |
| 52-Week High | $1.75 |
| 52-Week Low | $0.16 |
| Volume | 14.77K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-23.74M |
| Gross Margin | 0.00% |
1 analysts cover TOVX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.00.